Document Type

Article

Publication Date

12-1-2025

Keywords

JGM, Humans, Leukemia, Myeloid, Acute, Glyceraldehyde-3-Phosphate Dehydrogenases, Protein Biosynthesis, RNA, Messenger, RNA-Binding Proteins, 5' Untranslated Regions, Cell Line, Tumor, RNA Stability, Protein Binding, Gene Expression Regulation, Leukemic, Cell Proliferation, Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)

JAX Source

RNA Biol. 2025;22(1):1–23

ISSN

1555-8584

PMID

41175344

DOI

https://doi.org/10.1080/15476286.2025.2580180

Grant

E.W. is supported by The Jackson Laboratory Cancer Center (JAXCC) New Investigator Award (P30CA034196), JAX start-up funds, JAX Cancer Center Fast Forward Award, American Society of Hematology (ASH) Scholar Award, Leukemia Research Foundation (LRF), Alex’s Lemonade Stand Foundation for Childhood Cancer and Start-Up grant from Associazione Italiana Ricerca sul Cancro (AIRC)[26533]

Abstract

Dysregulation of RNA binding proteins (RBPs) is a hallmark in cancerous cells. In acute myeloid leukaemia (AML) RBPs are key regulators of tumour proliferation. While classical RBPs have defined RNA binding domains, RNA recognition and function in AML by non-canonical RBPs (ncRBPs) remain unclear. Given the inherent complexity of targeting AML broadly, our goal was to uncover potential ncRBP candidates critical for AML survival using a CRISPR/Cas-based screening. We identified the glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a pro-proliferative factor in AML cells. Based on cross-linking and immunoprecipitation (CLIP), we are defining the global targetome, detecting novel RNA targets mainly located within 5'UTRs, including GAPDH, RPL13a, and PKM. The knockdown of GAPDH unveiled genetic pathways related to ribosome biogenesis, translation initiation, and regulation. Moreover, we demonstrated a stabilizing effect through GAPDH binding to target transcripts including its own mRNA. The present findings provide new insights on the RNA functions and characteristics of GAPDH in AML.

Creative Commons License

Creative Commons Attribution 4.0 International License
This work is licensed under a Creative Commons Attribution 4.0 International License.

Share

COinS